Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and maintains $14.25 price target.
Cantor Fitzgerald Maintains Overweight on Cresco Labs, Maintains $14.25 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.